A Phase II trial is a critical stage in the clinical research of cancer treatments. It follows the initial safety assessments conducted in a Phase I trial and primarily aims to evaluate the efficacy of a new treatment. This phase involves a larger group of patients, typically ranging from 100 to 300 individuals, and provides more detailed information on the treatment's effectiveness and side effects.
